3/17
10:33 am
mgtx
MeiraGTx Holdings plc (NASDAQ: MGTX) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $13.00. They now have an "outperform" rating on the stock.
Low
Report
MeiraGTx Holdings plc (NASDAQ: MGTX) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $13.00. They now have an "outperform" rating on the stock.
3/13
08:40 am
mgtx
MeiraGTx rises after deal with Hologen to form joint venture [Seeking Alpha]
High
Report
MeiraGTx rises after deal with Hologen to form joint venture [Seeking Alpha]
3/13
08:00 am
mgtx
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
High
Report
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
3/13
07:30 am
mgtx
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
High
Report
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
3/6
08:08 am
mgtx
Forbes Daily: Automakers Get Coveted Carveout Amid Tariff Escalation [Forbes]
Low
Report
Forbes Daily: Automakers Get Coveted Carveout Amid Tariff Escalation [Forbes]
3/5
09:42 am
mgtx
This Founder’s Gene Therapy Company Helped Blind Kids See Again [Forbes]
Low
Report
This Founder’s Gene Therapy Company Helped Blind Kids See Again [Forbes]
3/4
01:07 pm
mgtx
All patients see benefit in Mass Brigham's cornea stem cell therapy trial [Yahoo! Finance]
Low
Report
All patients see benefit in Mass Brigham's cornea stem cell therapy trial [Yahoo! Finance]
3/4
11:08 am
mgtx
2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies [Yahoo! Finance]
Medium
Report
2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies [Yahoo! Finance]
2/24
08:16 am
mgtx
MeiraGTx Holdings plc (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $36.00 price target on the stock.
Medium
Report
MeiraGTx Holdings plc (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $36.00 price target on the stock.
2/24
07:42 am
mgtx
MeiraGTx seeks UK approval after gene therapy restores sight in children born blind [Yahoo! Finance]
Low
Report
MeiraGTx seeks UK approval after gene therapy restores sight in children born blind [Yahoo! Finance]
2/21
07:17 am
mgtx
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy [Yahoo! Finance]
Low
Report
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy [Yahoo! Finance]
2/21
06:30 am
mgtx
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
High
Report
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy